Q2 2026 net sales rose to $2,803 million (+3.3%, +1.0% organic), with operating margin at 6.8% and adjusted operating margin at 9.6%. Diluted EPS was $1.35 but declined 38%, suggesting profitability improved at the operating level while bottom-line results weakened. Overall, the report points to continued positive operating momentum into the full-year outlook (details truncated in the excerpt).
Q2 2026 net sales rose to $2,803 million (+3.3%, +1.0% organic), with operating margin at 6.8% and adjusted operating margin at 9.6%. Diluted EPS was $1.35 but declined 38%, suggesting profitability improved at the operating level while bottom-line results weakened. Overall, the report points to continued positive operating momentum into the full-year outlook (details truncated in the excerpt).
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.25
